title: [Pathophysiology of pulmonary hypertension: advances and prospects].
authors.forename: D
authors.initials: D
authors.lastname: Montani
authors.forename: C
authors.initials: C
authors.lastname: Guignabert
authors.forename: F
authors.initials: F
authors.lastname: Perros
authors.forename: M
authors.initials: M
authors.lastname: Humbert
mesh_terms: D019332:Endothelin-1 / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects / Q000276:immunology / Q000503:physiopathology*; D005346:Fibroblast Growth Factors / Q000378:metabolism; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D007074:Immunoglobulin G / Q000276:immunology; D020738:Leptin / Q000378:metabolism; D058628:Myofibroblasts / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism; D010982:Platelet-Derived Growth Factor / Q000378:metabolism; D011379:Prognosis; D044062:Prostaglandins I / Q000378:metabolism; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism; D017366:Serotonin Receptor Agonists / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D019332:Endothelin-1; D007074:Immunoglobulin G; D020738:Leptin; D010982:Platelet-Derived Growth Factor; D044062:Prostaglandins I; D047428:Protein Kinase Inhibitors; D017366:Serotonin Receptor Agonists; D009569:Nitric Oxide; D012701:Serotonin; D005346:Fibroblast Growth Factors